vimarsana.com

Page 90 - பழுப்பு ஸ்ரீ டாக்டர் நூர் ஹிஷாம் அப்துல்லா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

M sia to take part in phase three clinical trials for new Covid-19 vaccine from China, says Health DG

PETALING JAYA: Malaysia will participate in phase three clinical trials for a new vaccine manufactured by Chinese firm Shenzhen Kangtai Biological Products Co Ltd, says the Health Ministry. Health director-general Tan Sri Dr Noor Hisham Abdullah said the clinical study involving the inactivated vaccine was approved by the National Pharmaceutical Regulatory Agency (NPRA) on May 28. Phase three clinical study of this vaccine will be conducted in eight research centres in Malaysia targeting the participation of 3,000 adults aged 18 years and above and is expected to take 15 to 19 months. The Health Ministry would like to inform that there is an addition of one clinical study, involving the product SARS-CoV-2 Vaccine (Vero Cells), Inactivated, 5μg/0.5mL manufactured by Shenzhen Kangtai Biological Products Co Ltd from China.

NPRA approves clinical study of another Covid-19 vaccine, says Dr Noor Hisham | Malaysia

Saturday, 05 Jun 2021 05:07 PM MYT Health director-general Tan Sri Dr Noor Hisham Abdullah during a press conference reporting the daily update on the country’s Covid-19 situation at the Ministry of Health, May 8, 2021. Bernama pic Follow us on Instagram and subscribe to our Telegram channel for the latest updates. KUALA LUMPUR, June 5 The National Pharmaceutical Regulatory Agency (NPRA) has approved a clinical study of another Covid-19 vaccine, said Health director-general Tan Sri Dr Noor Hisham Abdullah. He said the clinical study involving the SARS-CoV-2 Vaccine (Vero Cells), inactivated, 5μg/0.5mL, manufactured by Shenzhen Kangtai Biological Products Co., Ltd. in China was approved on May 28.

Dr Noor Hisham: Health Ministry starts Ivermectin trial for high-risk Covid-19 patients | Malaysia

KUALA LUMPUR, June 5 The Ministry of Health (MOH) and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 MOH’s hospitals. Health director-general Tan Sri Dr Noor Hisham Abdullah said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.